Evidence map›Paper›PMID 39587695›Full record

ArticleBreast cancer research : BCR2024

The shared genetic landscape of polycystic ovary syndrome and breast cancer: convergence on ER + breast cancer but not ER- breast cancer.

Kaixin Bi, Miaoran Chen, Qianru Zhao, Tongtong Yang, Wenjia Xie, Wenqi Ma, Hongyan Jia

Abstract read
In one paragraph

Article in Breast cancer research : BCR, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kaixin Bi *Department of First Clinical Medicine, Shanxi Medical University, Taiyuan, China.
Miaoran Chen *Department of Second Clinical Medicine, Shanxi Medical University, Taiyuan, China.
Qianru ZhaoDepartment of Second Clinical Medicine, Shanxi Medical University, Taiyuan, China.
Tongtong YangSchool of Basic Medical Sciences, Shanxi Medical University, Taiyuan, China.
Wenjia XieDepartment of First Clinical Medicine, Shanxi Medical University, Taiyuan, China.
Wenqi MaSchool of Basic Medical Sciences, Shanxi Medical University, Taiyuan, China.
Hongyan JiaDepartment of Breast Surgery, First Hospital of Shanxi Medical University, Taiyuan, China. swallow_jhy@163.com.ORCID http://orcid.org/0000-0001-5631-498X

Funding

Key Laboratory of Cellular Physiology (Shanxi Medical University), Ministry of Education, China CPOF202310Research Project Supported by Shanxi Scholarship Council of China 2021-157Youth project of Shanxi Basic Research Program 202303021222339
6 · The paper itself

Abstract

backgroundThe clinically high comorbidity between polycystic ovary syndrome (PCOS) and breast cancer (BC) has been extensively reported. However, limited knowledge exists regarding their shared genetic basis and underlying mechanisms.

methodLeveraging summary statistics from the largest genome-wide association studies (GWASs) to date, we conducted a comprehensive genome-wide cross-trait analysis of PCOS and BC. A variety of genetic statistical methods were employed to uncover potential shared genetic causes.

resultsOur analysis revealed genetic overlap between the three trait pairs. After partitioning the genome into 2,495 independent regions, we identified two loci, chr8: 75,011,700-76,295,483 and chr17: 6,305,079-7,264,458, with significant localized genetic correlations. Pleiotropic analysis under a composite null hypothesis identified 1,183 significant pleiotropic single nucleotide polymorphisms (SNPs) across three trait pairs. FUMA mapped 26 pleiotropic loci, with regions 16q12.2 and 6q25.1 duplicated across all three trait pairs, while COLOC detected three loci with colocalization evidence. Gene-based analysis identified 23 unique candidate pleiotropic genes, including the FTO shared by all trait pairs, as well as SER1, RALB, and others in two trait pairs. Pathway enrichment analysis further highlighted key biological pathways, primarily involving the significant biological pathways were the metabolism of regulation of autophagy, regulation of cellular catabolic process, and positive regulation of catabolic process. Latent Heritable Confounder Mendelian randomization (LHC-MR) supported a positive causal relationship between PCOS and both BCALL and ERPBC but not with ERNBC.

conclusionIn conclusion, our genome-wide cross-trait analysis identified a shared genetic basis between PCOS and BC, specific identical genetic mechanisms and causality between PCOS and various BC subtypes, which could better explains the genetics of the co-morbidity of PCOS and ERPBC rather than PCOS and ERNBC. These findings provide new insights into the biological mechanisms underlying the co-morbidity of these two complex diseases, which have important implications for clinical disease intervention, treatment, and improved prognosis.

Indexed as

Breast NeoplasmsGenetic Predisposition to DiseaseGenome-Wide Association StudyPolycystic Ovary SyndromePolymorphism, Single NucleotideFemaleGenetic PleiotropyHumansQuantitative Trait LociReceptors, EstrogenReceptors, EstrogenBreast cancerGWASPolycystic ovary syndromeShared genetic

Identifiers

PMID39587695
PMCPMC11587662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.